Literature DB >> 26918473

Less-aggressive surgical management and long-term outcomes of jugular foramen paragangliomas: a neurosurgical perspective.

Da Li1,2,3,4, Xiao-Jun Zeng1,2,3,4, Shu-Yu Hao1,2,3,4, Liang Wang1,2,3,4, Jie Tang1, Xin-Ru Xiao1, Guo-Lu Meng1, Gui-Jun Jia1, Li-Wei Zhang1,2,3,4, Zhen Wu1,2,3,4, Jun-Ting Zhang1,2,3,4.   

Abstract

OBJECTIVE The aim of this study was to analyze the neurological functional outcome and recurrent risks in surgically treated jugular foramen paragangliomas (JFPs) and to propose an individualized therapeutic strategy. METHODS Clinical charts and radiological information were reviewed retrospectively in 51 consecutive cases of JFPs. Less-aggressive surgical interventions were adopted with the goal of preserving neurovascular structures. Scheduled follow-up was performed. RESULTS The mean age of the patients in the cases reviewed was 41.6 years, and the group included 27 females (52.9%). The mean preoperative Karnofsky Performance Scale (KPS) score was 78.4. The mean lesion size was 3.8 cm. Forty-three cases (84.3%) were Fisch Type D, including 37 cases (72.5%) of Type Di1 and Di2. Thirty-seven cases (72.5%) were Glasscock-Jackson Type III-IV. Gross-total resection and subtotal resection were achieved in 26 (51.0%) and 22 (43.1%) cases, respectively. Surgical morbidities occurred in 23 patients (45.1%), without surgery-related mortality after the first operation. The mean postoperative KPS scores at discharge, 3 months, 1 year, and most recent evaluation were 71.8, 77.2, 83.2, and 79.6, respectively. The mean follow-up duration was 85.7 months. The tumor recurrence/regrowth (R/R) rate was 11.8%. Compared with preoperative status, swallowing function improved or stabilized in 96.1% and facial function improved or stabilized in 94.1% of patients. A House-Brackmann scale Grade I/II was achieved in 43 patients (84.3%). Overall neurological status improved or stabilized in 90.0% of patients. Pathological mitosis (HR 10.640, p = 0.009) was the most significant risk for tumor R/R. A 1-year increase in age (OR 1.115, p = 0.037) and preoperative KPS score < 80 (OR 11.071, p = 0.018) indicated a risk for recent poor neurological function (KPS < 80). Overall R/R-free survival, symptom progression-free survival, and overall survival at 15 years were 78.9%, 86.8%, and 80.6%, respectively. CONCLUSIONS Surgical outcomes for JFPs were acceptable using a less-aggressive surgical strategy. Most patients could adapt to surgical morbidities and carry out normal life activities. Preserving neurological function was a priority, and maximal decompression with or without radiotherapy was desirable to preserve a patient's quality of life when radical resection was not warranted. Early surgery plus preoperative devascularization was proposed, and radiotherapy was mandatory for lesions with pathological mitosis.

Entities:  

Keywords:  CN = cranial nerve; ECA = external carotid artery; GKS = Gamma Knife surgery; GTR = gross-total resection; ICA = internal carotid artery; JFP = jugular foramen paraganglioma; KPS = Karnofsky Performance Scale; LCN = lower CN; PR = partial resection; R/R = recurrence/regrowth; STR = subtotal resection; VA = vertebral artery; glomus jugulare tumor; jugular foramen; oncology; paraganglioma; pathological mitosis

Mesh:

Year:  2016        PMID: 26918473     DOI: 10.3171/2015.10.JNS151875

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  4 in total

1.  Preservation of the facial and lower cranial nerves in glomus jugulare tumor surgery: modifying our surgical technique for improved outcomes.

Authors:  Rubens de Brito; Juan Carlos Cisneros Lesser; Paula Tardim Lopes; Ricardo Ferreira Bento
Journal:  Eur Arch Otorhinolaryngol       Date:  2018-06-01       Impact factor: 2.503

2.  Surgical treatment of selected tumors via the navigated minimally invasive presigmoidal suprabulbar infralabyrinthine approach without rerouting of the facial nerve.

Authors:  Zafer Cinibulak; Shadi Al-Afif; Makoto Nakamura; Joachim K Krauss
Journal:  Neurosurg Rev       Date:  2022-06-23       Impact factor: 2.800

3.  Head and neck paragangliomas: A two-decade institutional experience and algorithm for management.

Authors:  Joshua D Smith; Rachel N Harvey; Owen A Darr; Mark E Prince; Carol R Bradford; Gregory T Wolf; Tobias Else; Gregory J Basura
Journal:  Laryngoscope Investig Otolaryngol       Date:  2017-11-11

4.  Surgical management of embolized jugular foramen paragangliomas without facial nerve transposition: Experience of a public tertiary hospital in Brazil.

Authors:  Benedicto Oscar Colli; Carlos Gilberto Carlotti Junior; Ricardo Santos de Oliveira; Guilherme Gozzoli Podolski Gondim; Daniel Giansanti Abud; Eduardo Tanaka Massuda; Francisco Veríssimo de Melo Filho; Koji Tanaka
Journal:  Surg Neurol Int       Date:  2021-09-30
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.